The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jelinek, D. F.
Right arrow Articles by Lipsky, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jelinek, D. F.
Right arrow Articles by Lipsky, P. E.

The Journal of Immunology, Vol 130, Issue 6 2597-2604, Copyright © 1983 by American Association of Immunologists


ARTICLES

The role of B cell proliferation in the generation of immunoglobulin- secreting cells in man

DF Jelinek and PE Lipsky

The relationship of B cell proliferation and the generation of immunoglobulin-secreting cells (ISC) was explored in vitro by examining the effect of hydroxyurea (HU), an inhibitor of cellular DNA synthesis, on the generation of ISC from human peripheral blood mononuclear cells (PBM). HU completely inhibited the capacity of PBM to generate ISC in response to pokeweed mitogen (PWM) and other polyclonal B cell activators. Inhibition resulted from an effect on B cell proliferation, because HU also prevented the generation of ISC in cultures of purified B cells supplemented with either T cell supernatants or mitomycin C- treated T cells. Inhibiting B cell proliferation by treating them with mitomycin C before culture also abolished the generation of ISC. When ISC were enumerated after a 7-day incubation with PWM, the addition of HU as late as day 6 of culture was found to inhibit responsiveness markedly. This suggested that those cells that had acquired the capacity to secrete lg were actively dividing, and continued division was necessary for ongoing lg secretion. To examine this possibility, experiments were carried out in which responsiveness was assayed on a daily basis. ISC could be detected after a 3- or 4-day incubation and reached maximum at day 6 or 7. Addition of HU on days 3 to 7 caused a highly significant reduction in the number of ISC within 24 hr. ISC did not begin to show resistance to the effects of HU until later in culture. This observation supported the conclusions that ISC were a rapidly cycling cell population and that ongoing lg secretion, as well as expansion in the number of ISC, depended on continued proliferation of the ISC. To confirm directly that ISC were a cycling cell population, PBM were cultured with PWM for 6 days, fixed, stained for both cytoplasmic lg and DNA content, and analyzed on the fluorescence- activated cell sorter. This method made it possible to quantitate the DNA content of individual lg-synthesizing cells and thus to determine their position in the cell cycle. As many as 40% of cytoplasmic lg- positive cells were found to be in the S, G2, or M phases of the cell cycle. These data indicate that ISC generated in man after in vitro stimulation with a number of polyclonal activators are not stable terminally differentiated lg-secreting plasma cells but rather an actively cycling lg-secreting population. Furthermore, the results indicate that proliferation of the ISC themselves plays an important role in determining the magnitude of the resultant antibody response.


This article has been cited by other articles:


Home page
Int ImmunolHome page
A. Geffroy-Luseau, G. Jego, R. Bataille, L. Campion, and C. Pellat-Deceunynck
Osteoclasts support the survival of human plasma cells in vitro
Int. Immunol., June 1, 2008; 20(6): 775 - 782.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. L. Good, V. L. Bryant, and S. G. Tangye
Kinetics of Human B Cell Behavior and Amplification of Proliferative Responses following Stimulation with IL-21
J. Immunol., October 15, 2006; 177(8): 5236 - 5247.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Ettinger, G. P. Sims, A.-M. Fairhurst, R. Robbins, Y. S. da Silva, R. Spolski, W. J. Leonard, and P. E. Lipsky
IL-21 Induces Differentiation of Human Naive and Memory B Cells into Antibody-Secreting Plasma Cells
J. Immunol., December 15, 2005; 175(12): 7867 - 7879.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. Shapiro-Shelef, K.-I Lin, D. Savitsky, J. Liao, and K. Calame
Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow
J. Exp. Med., December 5, 2005; 202(11): 1471 - 1476.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Robillard, C. Pellat-Deceunynck, and R. Bataille
Phenotypic characterization of the human myeloma cell growth fraction
Blood, June 15, 2005; 105(12): 4845 - 4848.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. T. Avery, J. I. Ellyard, F. Mackay, L. M. Corcoran, P. D. Hodgkin, and S. G. Tangye
Increased Expression of CD27 on Activated Human Memory B Cells Correlates with Their Commitment to the Plasma Cell Lineage
J. Immunol., April 1, 2005; 174(7): 4034 - 4042.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Arce, E. Luger, G. Muehlinghaus, G. Cassese, A. Hauser, A. Horst, K. Lehnert, M. Odendahl, D. Honemann, K.-D. Heller, et al.
CD38 low IgG-secreting cells are precursors of various CD38 high-expressing plasma cell populations
J. Leukoc. Biol., June 1, 2004; 75(6): 1022 - 1028.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. G. Tangye, D. T. Avery, and P. D. Hodgkin
A Division-Linked Mechanism for the Rapid Generation of Ig-Secreting Cells from Human Memory B Cells
J. Immunol., January 1, 2003; 170(1): 261 - 269.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Jego, R. Bataille, and C. Pellat-Deceunynck
Interleukin-6 is a growth factor for nonmalignant human plasmablasts
Blood, March 15, 2001; 97(6): 1817 - 1822.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Jego, N. Robillard, D. Puthier, M. Amiot, F. Accard, D. Pineau, J.-L. Harousseau, R. Bataille, and C. Pellat-Deceunynck
Reactive Plasmacytoses Are Expansions of Plasmablasts Retaining the Capacity to Differentiate Into Plasma Cells
Blood, July 15, 1999; 94(2): 701 - 712.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1983 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1983 by The American Association of Immunologists, Inc. All rights reserved.